THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY : Impact Factor & More
eISSN: 2045-1261pISSN: 2045-1253
Open AccessShare this on:
Key Metrics
Impact Factor 
< 5
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY Journal Specifications
Indexed in the following public directories
Web of Science 
DOAJ 
SJR
| Overview | |
| Publisher | SAGE PUBLICATIONS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2300 |
| Publication Time | 10 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | British Association for Psychopharmacology |
| Frequency | Continuous publication |
| Publication Start Year | 2011 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY
Modafinil-associated psychosis: a systematic review of case characteristics and management strategies
- 10 May 2026
- Therapeutic Advances in Psychopharmacology
Clinical predictors of stimulant efficacy in adults with ADHD
- 3 Apr 2026
- Therapeutic Advances in Psychopharmacology
Intranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study
- 1 Apr 2026
- Therapeutic Advances in Psychopharmacology
Adult psychiatrists' views on clozapine prescribing for schizophrenia in Germany-an online survey.
- 1 Apr 2026
- Therapeutic advances in psychopharmacology
Clozapine-related neutropenia and agranulocytosis in Korea: 2025 update for rethinking the role of monitoring system.
- 1 Apr 2026
- Therapeutic advances in psychopharmacology
MicroRNAs in metabolic effects with atypical antipsychotics—a scoping review
- 31 Mar 2026
- Therapeutic Advances in Psychopharmacology
Modafinil-associated psychosis: a systematic review of case characteristics and management strategies
- 10 May 2026
- Therapeutic Advances in Psychopharmacology
Clinical predictors of stimulant efficacy in adults with ADHD
- 3 Apr 2026
- Therapeutic Advances in Psychopharmacology
Intranasal esketamine in treatment-resistant depression: long-term dosing patterns and clinical outcomes in a 5-year observational study
- 1 Apr 2026
- Therapeutic Advances in Psychopharmacology
Adult psychiatrists' views on clozapine prescribing for schizophrenia in Germany-an online survey.
- 1 Apr 2026
- Therapeutic advances in psychopharmacology
Clozapine-related neutropenia and agranulocytosis in Korea: 2025 update for rethinking the role of monitoring system.
- 1 Apr 2026
- Therapeutic advances in psychopharmacology
MicroRNAs in metabolic effects with atypical antipsychotics—a scoping review
- 31 Mar 2026
- Therapeutic Advances in Psychopharmacology
FAQs on THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY
How long has THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY been actively publishing? 
What is the publishing frequency of THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY?
How many articles did THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY publish last year?
What is the eISSN & pISSN for THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY?
Who is the publisher of THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY?
